INTERNATIONAL PATENT: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS FILES APPLICATION FOR "TREATMENT OF NEUROFIBROMATOSIS TYPE 2 BY INHIBITORS OF G6PD, ACSL3 AND/OR OXSM"

GENEVA, Dec. 22 -- DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (Im Neuenheimer Feld 28069120 Heidelberg) filed a patent application (PCT/EP2025/066359) for "TREATMENT OF NEUROFIBROMATOSIS TYPE 2 BY INHIBITORS OF G6PD, ACSL3 AND/OR OXSM" on Jun 12, 2025. With publication no. WO/2025/257301, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TELEMAN, Aurelio (c/o Deutsches KrebsforschungszentrumStiftung des offentlichen RechtsIm Neuenheimer Feld 28069120 Heidelberg), KYRKOU, Athina (c/o Deutsches Krebsfor...